Related Experiment Video
Updated: Jun 29, 2025

10:13
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
9.0K
PD-1 Limits IL-2 Production and Thymic Regulatory T Cell Development.
Breanna Caruso1, Benjamin R Weeder2, Reid F Thompson2,3,4,5
1Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR.
Immunohorizons
|March 29, 2024
Summary
Programmed cell death protein 1 (PD-1) regulates regulatory T cell (Treg) development in the thymus by modulating T cell receptor signaling and IL-2 production. This finding offers insights into immune checkpoint blockade therapies for cancer and infection.
Area of Science:
- Immunology
- Cell Biology
- Developmental Biology
Background:
- Programmed cell death protein 1 (PD-1) is an inhibitory receptor crucial for peripheral T cell responses.
- PD-1 expression is initiated during T cell development in the thymus, but its precise role in this process is unclear.
- Previous studies suggest PD-1 influences regulatory T cell (Treg) development, yet the underlying mechanisms remain elusive.
Purpose of the Study:
- To investigate the role of PD-1 and its ligands in the thymus during T cell development.
- To elucidate the mechanism by which PD-1 regulates Treg development.
- To explore the implications of PD-1's function in thymic Treg selection for immunotherapy.
Main Methods:
- Evaluation of PD-1 and programmed death-ligand 1 expression on thymic agonist-selected cells.
- Analysis of PD-1's impact on Treg proliferation, cell death, and T cell receptor (TCR) signaling in PD-1-deficient mice.
- Measurement of IL-2 production in thymocytes from PD-1-deficient and wild-type mice.
Main Results:
- High expression of PD-1 and its ligand was observed on agonist-selected cells in the thymus.
- PD-1 selectively regulates the developmental niche of Tregs, without affecting other agonist-selected populations like NKT cells.
- PD-1 deficiency in Tregs led to reduced TCR signaling and increased production of the Treg-limiting cytokine IL-2.
Conclusions:
- PD-1 plays a novel role in regulating IL-2 production and the agonist selection of murine thymic Tregs.
- These findings suggest a mechanism for PD-1 in controlling Treg homeostasis within the thymus.
- The study's results have significant implications for optimizing immune checkpoint blockade strategies in cancer and infectious diseases.

